About News News Subscribe Health Policy Economics Facet Area of Focus - News Craig Volden Benjamin Castleman Gerald Warburg Allan Stam Brian N. Williams Ian H. Solomon Kirsten Gelsdorf David Leblang Jennifer Lawless Lucy Bassett John Holbein Sebastian Tello-Trillo Sophie Trawalter Todd S. Sechser Daphna Bassok Jay Shimshack Philip Potter Sarah Turner Bala Mulloth Christine Mahoney Gabrielle Adams Harry Harding James R. Detert Jazmin Brown-Iannuzzi Margaret Foster Riley Michele Claibourn Raymond C. Scheppach Adam Leive Adam Roux Andrew S. Pennock Benjamin Converse Daniel W. Player Eileen Chou Galen Fountain George Foresman Gerald Higginbotham Jeanine Braithwaite Jieun Pai Kimberly Jenkins Robinson Michael D. Williams William Shobe (-) Christopher J. Ruhm Facet People - News Facet UVA Partner - News (-) Research and Commentary Facet News Type - News Jun 23, 2022 We May Not Have Been as Anxious, Depressed in Pandemic's First Year as Once Thought Health Policy Findings from the Batten School's Christopher Ruhm and colleagues at Harvard question the accuracy of the CDC’s Household Pulse survey on mental health. Learn more May 17, 2021 How to target opioid funding to states that need it most Health Policy Economics According to new research from Batten’s Christopher J. Ruhm, the federal government’s opioid grant funding structure favors the least populous states, which are not always the states with greatest need. In an op-ed for The Hill, Ruhm suggests several ways to improve the targeting of federal grants that aim to assist states with opioid problems. Read in The Hill Stay Up To Date with the Latest Batten News and Events Subscribe
Jun 23, 2022 We May Not Have Been as Anxious, Depressed in Pandemic's First Year as Once Thought Health Policy Findings from the Batten School's Christopher Ruhm and colleagues at Harvard question the accuracy of the CDC’s Household Pulse survey on mental health. Learn more
May 17, 2021 How to target opioid funding to states that need it most Health Policy Economics According to new research from Batten’s Christopher J. Ruhm, the federal government’s opioid grant funding structure favors the least populous states, which are not always the states with greatest need. In an op-ed for The Hill, Ruhm suggests several ways to improve the targeting of federal grants that aim to assist states with opioid problems. Read in The Hill